Markets.com Logo

BIOT

$--
--%
1d
1w
1m

Analysis and statistics

  • Open
    0.2077$
  • Previous Close
    0.2077$
  • 52 Week Change
    0.18$
  • Day Range
    0.00$
  • 52 Week High/Low
    0.18$ - 0.36$
  • Dividend Per Share
    --
  • Market cap
    3 447 K$
  • EPS
    -0.2991
  • Beta
    0.749
  • Volume
    --

About

BIOT.AT represents shares of BIOTRONIK SE & Co. KG, a German manufacturer of cardiovascular and endovascular medical devices. The company develops, produces, and distributes a range of products including pacemakers, implantable cardioverter-defibrillators (ICDs), coronary stents, and electrophysiology catheters. BIOTRONIK is privately held, and its shares trade on the open market in specific exchanges, denoted by the ".AT" extension which usually refers to the Vienna Stock Exchange, where it might have a listing or trading presence.

Fed Rate Cut Looming: Is It Time to Rethink the 2% Inflation Target?

Emma Rose|--

Federal Reserve Policy Shifts and Future Outlook: 2025-2026

Emma Rose|--

Oil Prices Rise After Israeli Strike on Hamas Leader in Qatar: A Market Overview

Sophia Claire|--

Weak Job Market, Rising Inflation: Will the Fed Cut Rates?

Liam James|--
XRP Price Prediction: XRP (Ripple) Is Down, Will XRP/USD Soar Again?

XRP Price Prediction: XRP (Ripple) Is Down, Will XRP/USD Soar Again?

Ghko B|--
Nio Stock Is Climbing Today: What's the Target Price for Nio Inc Stock?

Nio Stock Is Climbing Today: What's the Target Price for Nio Inc Stock?

Ghko B|--
Gold Price (XAUUSD) Hits ATH: Economic Shifts, Fed Rate Cut, Jobs Data

Gold Price (XAUUSD) Hits ATH: Economic Shifts, Fed Rate Cut, Jobs Data

Ghko B|--

Factors

Company Performance: Revenue growth, profitability, and successful drug development progress positively impact the stock price.

Clinical Trial Results: Positive clinical trial outcomes for BIOT.AT's pipeline products significantly boost investor confidence and share value.

Regulatory Approvals: Approval of drugs by regulatory bodies like the FDA or EMA leads to market access and revenue potential, driving the stock price up.

Market Sentiment: Overall investor optimism or pessimism in the biotechnology sector affects BIOT.AT's stock price.

Competition: Competitor's success or failure in similar therapeutic areas impacts investor perception of BIOT.AT's market share and profitability.

Partnerships & Acquisitions: Strategic collaborations or acquisitions can increase BIOT.AT's value and influence the stock price.

Economic Conditions: Broader economic factors like interest rates and inflation can impact investor risk appetite and therefore biotech stocks.

News & Media Coverage: Positive or negative news reports can significantly affect investor sentiment and trading activity, influencing the stock price.

Analyst Ratings: Recommendations from financial analysts can influence investor decisions and impact the demand for BIOT.AT shares.

People Also Watch

Latest news

Senate Committee Approves Milan Fed Nomination: Implications and Analysis

Sophia Claire|--

CPI Report Preview: Wall Street Expects Inflation but Braces for Muted Market Reaction

Emma Rose|--

US PPI Signals Easing Inflation: What It Means for Fed Rate Decisions

Liam James|--

Latest Education Articles

Broadcom Stock Is Trending: How to Trade Broadcom Stock (AVGO) CFD?

Broadcom Stock Is Trending: How to Trade Broadcom Stock (AVGO) CFD?

Frances Wang|--
5 Tips on How to Trade Indices CFDs for Beginners: Dow, S&P 500, Nasdaq

5 Tips on How to Trade Indices CFDs for Beginners: Dow, S&P 500, Nasdaq

Frances Wang|--
CFD Leverage Explained: How Does Leverage Affect CFD Trading?

CFD Leverage Explained: How Does Leverage Affect CFD Trading?

Frances Wang|--